Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19.
Am J Emerg Med
; 61: 235.e5-235.e6, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2075854
ABSTRACT
The return of COVID-19 symptoms after Nirmatrelvir/Ritonavir (Nm/R) treatment is being increasingly reported. Limited evidence suggests most cases of rebound symptoms are mild and do not require further intervention. Here we present a male veteran reporting rebound symptoms who was found to be hypoxic with pulmonary emboli. Our case highlights the need to evaluate known complications of SARS-CoV-2 including venous thromboembolism in patients reporting recurring symptoms. Further, cases of severe rebound phenomenon should continue to be reported by clinicians to better appreciate the use of the Nm/R during the Omicron wave and among vaccinated persons.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Embolia Pulmonar
/
COVID-19
Tipo de estudio:
Reporte de caso
/
Estudio experimental
Tópicos:
Vacunas
/
Variantes
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Am J Emerg Med
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS